- Conditions
- Herpes Simplex
- Interventions
- GSK208141, Havrix (investigational formulation), Placebo
- Biological
- Lead sponsor
- GlaxoSmithKline
- Industry
- Eligibility
- 10 Years to 17 Years · Female only
- Enrollment
- 5,960 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2004 – 2007
- U.S. locations
- 66
- States / cities
- Birmingham, Alabama • Chandler, Arizona • Mesa, Arizona + 54 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–3
of 3
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Prophylaxis for Herpes Simplex
- Interventions
- Herpes simplex candidate vaccine- adjuvanted GSK 208141, Placebo
- Biological
- Lead sponsor
- GlaxoSmithKline
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 7,460 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 1996 – 1999
- U.S. locations
- 36
- States / cities
- La Jolla, California • Middle Valley, California • San Diego, California + 31 more
- Conditions
- Herpes Simplex
- Interventions
- GSK208141 vaccine
- Biological
- Lead sponsor
- GlaxoSmithKline
- Industry
- Eligibility
- 10 Years to 17 Years · Female only
- Enrollment
- 671 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2003 – 2006
- U.S. locations
- 9
- States / cities
- Mesa, Arizona • Fountain Valley, California • Golden, Colorado + 5 more